The market for Skin Cancer Detection Devices is expected to be worth US$ 959.6 million in 2023. The market is expected to exceed US$ 2.95 billion by 2033, growing at an 11.9% CAGR during the forecast period. Growing skin cancer incidences and skin cancer awareness are driving market growth. Because skin cancer affects people of …
Category Archives: Healthcare Trends
Elevating Therapeutics: Small Molecule-Drug Conjugates Market Anticipated to Reach US$ 3.65 Billion by 2033
According to a recent market survey conducted by Future Market Insights (FMI), the global Small Molecule-Drug Conjugates Market will be valued at US$ 1.18 billion in 2026 and is expected to reach US$ 3.65 billion by 2033.The increased use of personalised medicines is propelling market growth. Small molecule drug conjugates (SMDCs), a promising strategy for …
Spinal Injectable Market on a Remarkable Ascent: Expected to Reach US$ 51.2 Billion by 2033
In 2023, the Spinal Injectable Market is expected to be worth US$23.3 billion. The market is expected to exceed US$ 51.2 billion by 2033, growing at an 8.2% CAGR during the forecast period. Because of the exponentially increasing prevalence of chronic lower back pain, the global market for spinal injectables is expected to grow at …
Revolutionizing Cardiac Care: Predicting the Future Trends of the MRI Safe Defibrillator Market through 2029
The MRI Safe Defibrillator Market has exhibited steady growth from 2019 to 2029, fueled by increasing demand for technologically advanced and safe medical devices. This period saw a surge in adoption due to rising awareness about MRI-compatible defibrillators. The market’s expansion is projected to continue as medical facilities prioritize patient safety during MRI procedures, driving …
Peptide Antibiotics Market Poised for Remarkable 6.6% CAGR Growth, Projected to Reach US$ 8.3 Billion by 2032
At the end of 2021, the global Peptide Antibiotics Market was estimated to be worth approximately US$ 4.4 billion. The market is expected to grow at a 6.6% CAGR and reach a value of US$ 8.3 billion by 2032. Given the increased prevalence of illnesses such as bloodstream infections, hospital-acquired infections, and bacterial skin infections, the …
Biosimilars and Biologics Market Poised for Remarkable 15.5% CAGR Growth, Eyeing US$95 Billion by 2032
The Biosimilars and Biologics Market is expected to grow at a CAGR of 15.5% during the period 2022-2032. The market is valued at US$ 22,490.62 Mn in 2022 and is expected to reach a valuation of US$ 95,021.37 Mn by 2032. FMI, in its business report, elaborates the historical and current scenario of the global Biosimilars and …
Automated Sample Storage Systems Future Trends in Biotechnology: Forecasting a CAGR of 11.8%, to Surpass US$3.3 Billion by 2032
In 2022, it is anticipated that the market for Automated Sample Storage Systems will be worth US$ 992.5 million, rising to US$ 3,395.6 million in 2032. During the aforementioned time frame, a CAGR of 11.8% is forecast for the market. The rising demand for automated sample storage in industries like biotechnology, chemicals, pharmaceuticals, and others can be …
Breath Analyzers Market Soars to Anticipated US$3.40 Billion by 2032, Propelled by Robust 17% CAGR Growth
The Breath Analyzers Market is projected liable to enroll a CAGR of 17% during the gauge time frame, up from US$ 613 Mn in 2021 to arrive at a valuation of US$ 3.40 Bn by 2032. The Global study provides critical information related to the global, regional and top players including Breath Analyzers market share analysis, …
Life Science and Chemical Instruments Market to Surge at 5.3% CAGR till 2032 | Future Market Insights
The Life Science and Chemical Instruments Market is anticipated to increase from US$ 40.7 million in 2021 to US$ 43.8 million in 2026, with a CAGR of 5.3% from 2022 to 2032. Life science and chemical instruments have major applications in research and development centers, educational institutes, and clinical laboratories. The life science and chemical instruments market is dependent …
Eyes on Growth: Diabetic Retinopathy Market Poised to Hit US$15.50 Billion by 2033, Propelled by 5.8% CAGR
From 2023 to 2033, the Diabetic Retinopathy Market is expected to develop at a 5.8% CAGR. In 2023, the market share is expected to be worth $8.82 billion US$. Future Market Insights (FMI) caters to all the needs of the clients working in the international healthcare, pharmaceutical, and medical device industries with its 1000+ market …